基于天青蛋白的肽p28阻断p53-HDM2相互作用：一种新型抗癌途径
Azurin-Based Peptide p28 Arrests the p53-HDM2 Interactions: A Novel Anti-Cancer Pathway
AI总结：
本研究通过分子模拟发现天青蛋白衍生肽p28能阻断HDM2与p53的相互作用，维持p53转录活性，增强其抗癌功能，为肽类抗癌治疗提供新思路。
摘要：
天青蛋白及其衍生肽，尤其是p28，表现出显著的抗癌特性，主要通过稳定肿瘤抑制蛋白p53并防止其降解来实现。先前的研究表明，p28与p53的DNA结合域结合，保护其免受降解机制的影响。在这些发现的基础上，我们的研究探讨了p28是否在p53稳定化之外还作用于其他癌症途径。具体而言，我们检查了p28与人双微体2（HDM2）之间的相互作用，HDM2是一种通过结合p53的转激活域（TAD）来下调p53肿瘤抑制活性的蛋白质。HDM2在削弱p53功能中至关重要，我们的研究旨在确定p28是否破坏这种HDM2-p53相互作用。使用HADDOCK对接和分子动力学模拟，我们确定了HDM2-p28复合物的三种稳定构象。这些构象有效阻断HDM2的疏水口袋，允许持续的链间相互作用，并显示出有利的结合能。进一步分析指出了这些相互作用中的关键残基，我们使用分子力学泊松-玻尔兹曼表面积（MMPBSA）方法计算了相互作用能。我们的发现揭示，通过阻断HDM2的结合位点，p28有助于维持p53的转录活性，从而增强其肿瘤抑制功能，包括癌细胞中的凋亡和细胞周期阻滞。这项研究加深了对天青蛋白衍生肽抗癌机制的理解，并强调了p28作为肽类抗癌剂的潜力。这些发现还表明，有可能设计针对HDM2和其他癌症相关途径的额外肽疗法，为抗癌治疗开辟新方向。
英文摘要：
Azurin and its derived peptides, notably p28, exhibit significant anticancer properties, primarily by stabilizing the tumor suppressor protein p53 and preventing its degradation. Previous studies have shown that p28 binds to p53's DNA-binding domain, protecting it from degradation mechanisms. Expanding on these findings, our research explored whether p28 acts on additional cancer pathways beyond p53 stabilization. Specifically, we examined the interactions between p28 and Human Double Minute 2 (HDM2), a protein that downregulates p53's tumor-suppressive activity by binding to its transactivation domain (TAD). HDM2 is crucial in diminishing p53's function, and our study aimed to determine if p28 disrupts this HDM2-p53 interaction. Using HADDOCK docking and molecular dynamics simulations, we identified three stable conformations of the HDM2-p28 complex. These conformations effectively block HDM2's hydrophobic pocket, allowing for sustained inter-chain interactions and showing favorable binding energies. Further analysis pinpointed essential residues in these interactions, and we calculated interaction energies using the Molecular Mechanics Poisson-Boltzmann Surface Area (MMPBSA) method. Our findings reveal that by blocking HDM2's binding sites, p28 helps maintain p53's transcriptional activity, thus enhancing its tumor-suppressive functions, including apoptosis and cell cycle arrest in cancer cells. This study enhances understanding of azurin-derived peptides' anticancer mechanisms and highlights p28's potential as a peptide-based anticancer agent. These findings also suggest the possibility of designing additional peptide therapies targeting HDM2 and other cancer-related pathways, opening new directions in anticancer therapeutics.
机构、总结、中文摘要均由AI分析而来，可能存在错误，请以论文正文为准。
